HealthSouth Corporation (NYSE:HLS)‘s stock had its “hold” rating reissued by investment analysts at KeyCorp in a report released on Thursday.

A number of other brokerages also recently weighed in on HLS. Zacks Investment Research upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 price objective on the stock in a research report on Thursday, June 29th. Royal Bank Of Canada reiterated a “buy” rating and issued a $53.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Mizuho increased their price target on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the stock a “neutral” rating in a research report on Monday, July 10th. BidaskClub upgraded shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Finally, ValuEngine upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating in a research report on Friday, July 7th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the stock. HealthSouth Corporation presently has an average rating of “Hold” and an average target price of $49.71.

HealthSouth Corporation (NYSE:HLS) traded down 0.51% during midday trading on Thursday, hitting $44.73. 642,352 shares of the company were exchanged. The stock has a 50 day moving average of $44.14 and a 200-day moving average of $44.79. The stock has a market capitalization of $4.42 billion, a price-to-earnings ratio of 16.30 and a beta of 0.59. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71.

HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings data on Monday, July 31st. The company reported $0.71 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.68 by $0.03. The company had revenue of $981.30 million for the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.69 earnings per share. Equities analysts expect that HealthSouth Corporation will post $2.71 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This story was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/09/08/healthsouth-corporation-hls-rating-reiterated-by-keycorp.html.

In related news, CEO Mark J. Tarr sold 22,625 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at $12,174,762. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.60% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Neuburgh Advisers LLC grew its stake in HealthSouth Corporation by 40.1% during the first quarter. Neuburgh Advisers LLC now owns 3,072 shares of the company’s stock valued at $132,000 after acquiring an additional 880 shares in the last quarter. First Mercantile Trust Co. grew its stake in HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after acquiring an additional 430 shares in the last quarter. Acrospire Investment Management LLC grew its stake in HealthSouth Corporation by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after acquiring an additional 1,100 shares in the last quarter. Advisor Group Inc. grew its stake in HealthSouth Corporation by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after acquiring an additional 781 shares in the last quarter. Finally, Glen Harbor Capital Management LLC grew its stake in HealthSouth Corporation by 40.1% during the first quarter. Glen Harbor Capital Management LLC now owns 4,224 shares of the company’s stock valued at $181,000 after acquiring an additional 1,210 shares in the last quarter. 93.10% of the stock is owned by institutional investors.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.